Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Julphar
Queensland Health
Federal Trade Commission
Farmers Insurance
QuintilesIMS

Generated: September 16, 2019

DrugPatentWatch Database Preview

Celecoxib - Generic Drug Details

  Try a free trial


See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for celecoxib and what is the scope of celecoxib patent protection?

Celecoxib is the generic ingredient in two branded drugs marketed by Gd Searle, Alembic Pharms Ltd, Amneal Pharms, Apotex Inc, Aurobindo Pharma Ltd, Cipla, Cspc Ouyi, Jubilant Generics, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, Mylan, Teva, Torrent, and Watson Labs Inc, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for celecoxib. Fifty-eight suppliers are listed for this compound.

Pharmacology for celecoxib
Medical Subject Heading (MeSH) Categories for celecoxib
Synonyms for celecoxib
169590-42-5
184007-95-2
194044-54-7
1oq5
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide
4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-pyrazol-1-yl]benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
5-(4-Methylphenyl)-1-(4-sulfamoylphenyl)-3-(trifluoromethyl)pyrazole
590C425
A25046
AB00052396_10
AB00052396_11
AB00052396-07
AB00052396-08
AB00052396-09
AB0012055
ABP000291
AC-4228
AC1L1E6K
ACT02648
AI-525
AKOS015842517
AM84588
AN-12211
AT-3762
BBL029086
BC209720
BCP02156
BCP9000507
BCPP000290
BDBM11639
Benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-
benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-
Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)
Benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-
BIDD:GT0408
BP-30217
BRD-K02637541-001-02-4
BRD-K02637541-001-06-5
BSPBio_003596
C-6317
C07589
C17H14F3N3O2S
CAS-169590-42-5
CCG-39354
CCRIS 8679
CCRIS 9330
CELEBCOXIB
Celebra
Celebrex
Celebrex (TN)
Celebrex, Celebra, 169590-42-5
Celecox
Celecoxi
Celecoxib (JAN/USAN/INN)
Celecoxib (SC-58635)
Celecoxib [Old RN]
Celecoxib [USAN:INN:BAN]
Celecoxib [USAN]
Celecoxib 1.0 mg/ml in Acetonitrile
Celecoxib, >=98% (HPLC)
Celecoxib, European Pharmacopoeia (EP) Reference Standard
Celecoxib, Pharmaceutical Secondary Standard; Certified Reference Material
Celecoxib, United States Pharmacopeia (USP) Reference Standard
Celecoxib/Celebrex, Celebra
Celecoxib|169590-42-5|Celebrex|SC 58635
Celecoxibum
Celocoxib
CEP-33222
CHEBI:41423
CHEMBL118
cid_2662
CJ-016377
cMAP_000027
CP-598107
CPD000550473
CS-0570
CTK8H4475
D00567
DB00482
DivK1c_000893
DSSTox_CID_2777
DSSTox_GSID_22777
DSSTox_RID_76725
DTXSID0022777
EBD24636
EX-A175
FT-0080064
FT-0601628
FT-0623536
FT-0700357
GTPL2892
HMS1922G14
HMS2089L18
HMS2093I07
HMS2234N18
HMS3259L08
HMS3261A14
HMS3373A09
HMS3654H09
HMS3715F11
HMS502M15
HSDB 7038
HY-14398
I01-1033
IDI1_000893
J-010566
J-520011
J10035
JCX84Q7J1L
KB-76000
KBio1_000893
KBio2_000912
KBio2_002351
KBio2_003480
KBio2_004919
KBio2_006048
KBio2_007487
KBio3_002830
KBio3_003037
KBioGR_000723
KBioGR_002351
KBioSS_000912
KBioSS_002354
KS-00000FW2
KS-1041
LS-31667
MCULE-4750749400
MFCD00941298
MLS001165684
MLS001195656
MLS001304708
MLS006011862
MolPort-002-885-815
NC00708
NCGC00091455-01
NCGC00091455-02
NCGC00091455-03
NCGC00091455-04
NCGC00091455-05
NCGC00091455-06
NCGC00091455-07
NCGC00091455-08
NCGC00091455-09
NCGC00091455-13
NCGC00254540-01
NCGC00259513-01
NCGC00261091-01
NCI60_041049
NINDS_000893
NSC-719627
NSC-758624
NSC719627
NSC758624
Onsenal
Onsenal (TN)
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
PF-00345549
PHA-00846533
Pharmakon1600-01503678
Q-200816
RL02184
RZEKVGVHFLEQIL-UHFFFAOYSA-N
s1261
SAM002589995
SB19318
SBI-0051875.P002
SC 58635
SC 58635; Celebrex; Celebra
SC-50829
SC-58553, SC-58635
SC-58635
SC58635
SCHEMBL3708
SMR000550473
Solexa
SPBio_001512
Spectrum_000432
SPECTRUM1503678
Spectrum2_001576
Spectrum3_001996
Spectrum4_000182
Spectrum5_001324
SR-01000837528
SR-01000837528-2
SR-01000837528-3
STL373576
SW199611-3
SYN3015
TL8001323
Tox21_111135
Tox21_111135_1
Tox21_201964
Tox21_300599
Tox21_500406
TPI-336
UNII-JCX84Q7J1L
UNM-0000305813
US8741944, Comparative Compound
Xilebao
YM 177
YM-177
YM177
Z2210694606
ZINC2570895

US Patents and Regulatory Information for celecoxib

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cipla CELECOXIB celecoxib CAPSULE;ORAL 207446-001 Sep 23, 2015 AB RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Lupin Ltd CELECOXIB celecoxib CAPSULE;ORAL 202240-004 Jun 9, 2015 AB RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Watson Labs Inc CELECOXIB celecoxib CAPSULE;ORAL 200562-004 Feb 11, 2015 AB RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Alembic Pharms Ltd CELECOXIB celecoxib CAPSULE;ORAL 204519-001 Aug 21, 2015 AB RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Apotex Inc CELECOXIB celecoxib CAPSULE;ORAL 204197-002 Jun 2, 2015 AB RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Jubilant Generics CELECOXIB celecoxib CAPSULE;ORAL 207061-004 Apr 4, 2017 AB RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Cspc Ouyi CELECOXIB celecoxib CAPSULE;ORAL 210071-001 Jan 23, 2018 AB RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for celecoxib

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-002 Dec 31, 1998   Try a Free Trial   Try a Free Trial
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-003 Aug 29, 2002   Try a Free Trial   Try a Free Trial
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-002 Dec 31, 1998   Try a Free Trial   Try a Free Trial
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-003 Aug 29, 2002   Try a Free Trial   Try a Free Trial
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-004 Dec 15, 2006   Try a Free Trial   Try a Free Trial
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-001 Dec 31, 1998   Try a Free Trial   Try a Free Trial
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-003 Aug 29, 2002   Try a Free Trial   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Healthtrust
UBS
Queensland Health
Cipla
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.